UPMC Hillman Cancer Center @ Passavant - HOA

Clinical research site in Pittsburgh, Pennsylvania

As of July 2026, 1 paid clinical trial is recruiting at UPMC Hillman Cancer Center @ Passavant - HOA in Pittsburgh, Pennsylvania. Active studies at this site focus on Colorectal Neoplasms alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at UPMC Hillman Cancer Center @ Passavant - HOA (1)

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for Colorectal Neoplasms

104 locations incl. Glendale

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT05253651·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Explore more

Paid clinical trials in Pittsburgh, PA · Pennsylvania clinical trials

UPMC Hillman Cancer Center @ Passavant - HOA

Recruiting clinical trials at UPMC Hillman Cancer Center @ Passavant - HOA (1)

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

More research sites in Pittsburgh

Explore more